This study, titled "Early Nicotine or Diazepam Exposure Induces Long-Term Sleep Changes and Hippocampal Corticosteroid Receptor Downregulation in Adult Mice," was published in a scientific journal with the goal of determining the effects of nicotine and its byproducts on adults who were exposed during the perinatal period.
A research team exposed pregnant mice to passive smoking levels of nicotine and discovered that as adults, these mice had a significant reduction in sleep between resting and active phases.
According to Professor Giovanna Zoccoli, a researcher from the Department of Biomedical and Neuromotor Sciences at the University of Bologna, "The findings of this study suggest that adult sleep may be influenced by events that occurred in early life". "Based on our data, controlling environmental factors during pregnancy is crucial not only for women's health but also for the health of their offspring.
The study also found that this prenatal smoking exposure altered the expression and balance of hippocampal cortical hormone receptors. Zuccolini also added, "Our data suggests that sleep changes and downregulation of hippocampal cortical hormones occur simultaneously." "These results indicate that nicotine intake during pregnancy is a stress factor that affects the hippocampus development of offspring and their adult sleep patterns.
Do electronic cigarettes have an adverse effect on the heart?
A recent study exposed the heart cells of mice to vapor in a petri dish, concluding that vaping is harmful to the heart. Award-winning science writer, bestselling author, and chairman of the American Council on Science and Health, Hank Campbell explains why these findings are flawed.
A research report titled "In Vitro and In Vivo Cardiac Toxicity of Flavoring Nicotine E-Cigarettes" states that mice who inhaled vanillin had increased sympathetic nervous system dominance in heart rate variability measurements. Campbell stated, "A new paper claims that vaping, not smoking, puts the heart at risk, but their research does not support this claim. Instead, they mixed chemicals with heart cells in a petri dish and conducted experiments on mice. Both experiments are good exploratory studies, but scientifically, they cannot support the authors' conclusions stated in their press release.
According to Campbell, 'Mice aren't humans. If the FDA only studied them or cells grown in petri dishes, no drugs would ever make it to the approval process.' Furthermore, he explained that in this study, HL-1 cells from mice and later human cells produced in the lab were inundated with a large amount of chemicals from e-cigarettes that the human body wouldn't come into contact with for another 40,000 years.
Statement
This article is compiled from third-party information and is intended for industry-related communication and learning purposes only.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of the content. The translation of this article is only intended for industry communication and research purposes.
Due to limitations in the level of translation, the translated article may not express the original language accurately. Please refer to the original language for accuracy.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign statements and positions.
The compilation of information is the property of the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
